Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Artículos Relacionados
Comentarios
Deja un comentario
Todos los campos son requeridos
Más Vistas
- Capitán San Luis: el mejor hombre de la guerrilla
- Presidente Maduro exige a Bukele liberar a venezolanos encarcelados en El Salvador
- General de Ejército Raúl Castro expresa pesar por deceso del papa Francisco
- Luto en el mundo por la muerte del papa Francisco
- Presidente Díaz-Canel asiste a Cuba Salud 2025, cita por el bienestar universal (+Fotos)
